英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
multiplicare查看　multiplicare　在百度字典中的解释百度英翻中〔查看〕
multiplicare查看　multiplicare　在Google字典中的解释Google英翻中〔查看〕
multiplicare查看　multiplicare　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Xencor | Designing Proteins Delivering Medicines™
    Xencor is expanding the therapeutic boundaries of antibody drugs Powered by its XmAb ® protein engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat patients with cancer and other serious diseases
  • Xencor Inc. Stock Quote (U. S. : Nasdaq) - MarketWatch
    Xencor, Inc is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases
  • Xencor (XNCR) Stock Price Overview
    A detailed overview of Xencor, Inc (XNCR) stock, including real-time price, chart, key statistics, news, and more
  • Xencor Inc (XNCR) Stock News Articles - 24 7 Wall St.
    Xencor Inc is a pioneering biopharmaceutical company based in Pasadena, California, dedicated to developing innovative antibody and cytokine therapeutics for cancer and autoimmune diseases With a
  • Xencor, Inc. (XNCR) Stock Price, News, Quote History - Yahoo Finance
    Find the latest Xencor, Inc (XNCR) stock quote, history, news and other vital information to help you with your stock trading and investing
  • Xencor (XNCR) Stock Price, News Analysis - MarketBeat
    Xencor, Inc is a clinical-stage biopharmaceutical company focused on the design and development of engineered protein therapeutics for the treatment of autoimmune diseases, cancer and neurological disorders
  • XNCR | Xencor Inc. Stock Overview (U. S. : Nasdaq) | Barrons
    Complete Xencor Inc stock information by Barron's View real-time XNCR stock price and news, along with industry-best analysis
  • Company Overview - XNCR - NASDAQ - Weiss Ratings
    Company Overview Xencor, Inc is a publicly traded clinical-stage biotechnology company focused on the discovery and development of engineered monoclonal antibodies and cytokines for the treatment of cancer and immune-related diseases The company operates within the biopharmaceutical and biotechnology industries, with core expertise in protein engineering technologies that enhance the
  • Xencor, Inc. (XNCR): JP Morgan Assigns Neutral Rating as Analysts Find . . .
    In a recent shift of sentiment, Xencor, Inc (NASDAQ: XNCR) received a Neutral rating from Brian Cheng at JP Morgan on March 24, 2026 This decision comes as the stock currently hovers around $11 89, slightly below its average price target of $20, suggesting a notable upside potential should market conditions favor the biotech firm Recent Price Action Xencor’s stock has seen a degree of
  • Xencor downgraded to Neutral from Overweight at JPMorgan
    JPMorgan downgraded Xencor (XNCR) to Neutral from Overweight with a price target of $13, down from $18 The firm views the company’s 2026 as an “execution year ” Xencor’s pipeline will need time to develop, the analyst tells investors in a research note Claim 30% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of





中文字典-英文字典  2005-2009